Leavell Investment Management Inc. Sells 500 Shares of Chemed Co. (NYSE:CHE)

Leavell Investment Management Inc. decreased its stake in shares of Chemed Co. (NYSE:CHE) by 20.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,000 shares of the company’s stock after selling 500 shares during the period. Leavell Investment Management Inc.’s holdings in Chemed were worth $1,060,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. UMB Bank n.a. increased its position in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new position in Chemed during the fourth quarter worth $34,000. Farther Finance Advisors LLC boosted its holdings in Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after purchasing an additional 324 shares during the last quarter. KBC Group NV boosted its holdings in Chemed by 11.5% during the third quarter. KBC Group NV now owns 378 shares of the company’s stock worth $227,000 after purchasing an additional 39 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in Chemed by 59.8% during the third quarter. Venturi Wealth Management LLC now owns 425 shares of the company’s stock worth $255,000 after purchasing an additional 159 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $560.47 on Friday. The stock has a market cap of $8.44 billion, a P/E ratio of 28.32, a P/E/G ratio of 2.16 and a beta of 0.48. The company has a fifty day moving average price of $542.24 and a two-hundred day moving average price of $564.74. Chemed Co. has a one year low of $512.12 and a one year high of $654.62.

Insider Buying and Selling at Chemed

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares in the company, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company’s stock.

Wall Street Analyst Weigh In

CHE has been the subject of several recent research reports. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.